Related Experiment Videos
[Cell division, cytolysis and regeneration after cyclophosphamide]
Schweizerische Medizinische Wochenschrift
|October 2, 1976
Summary
High-dose cyclophosphamide temporarily halts lymphoid cell division and impairs neutrophil precursor proliferation in calves. Feedback mechanisms on GO/G1 cells regulate lymphoid cell proliferation following chemotherapy.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Context:
- Cyclophosphamide is a widely used chemotherapy agent with known immunosuppressive effects.
- Understanding its impact on cell division and immune cell populations is crucial for managing treatment side effects.
- Calves serve as a relevant model for studying mammalian immune responses.
Purpose:
- To investigate the cytokinetic effects of cyclophosphamide on thoracic duct lymph and blood cells in calves.
- To determine the dose-dependent impact of cyclophosphamide on lymphoid cell division and neutrophil precursor proliferation.
- To elucidate the role of feedback mechanisms in regulating lymphoid cell proliferation post-chemotherapy.
Summary:
- Administration of 5 or 20 mg/kg cyclophosphamide to calves was analyzed for its effects on thoracic duct lymph and blood cells.
- The higher dose (20 mg/kg) induced a transient halt in lymphoid cell division.
- This dose also reduced the output of non-dividing small lymphocytes and impaired neutrophil precursor proliferation, indicating significant bone marrow suppression.
Impact:
- Reveals the specific cellular mechanisms by which cyclophosphamide affects immune cell populations in young mammals.
- Highlights the importance of dose-dependent effects in chemotherapy-induced cytopenias.
- Suggests that feedback regulation at the GO/G1 phase plays a key role in the recovery of lymphoid cell populations after cytotoxic insult.